-
- Thomas Hotopp.
- Medizinisches Versorgungszentrum des Deutschen Roten Kreuzes, An der Wipper 2, 06567, Bad Frankenhausen, Germany. Electronic address: thomas.hotopp@kliniken-drk.de.
- Surg Oncol. 2019 Mar 1; 28: 159-166.
BackgroundGastric cancer with the presence of peritoneal metastases (pmgc) is associated with a very poor prognosis. Despite the wide utilization and promising results of the multimodal treatment regimens including cytoreductive surgery (CRS) and a subsequent hyperthermic intraperitoneal chemotherapy (HIPEC), it is still not fully understood which patient group is suitable for this treatment.MethodsTwenty-six patients (median age 53 years, range 39-71) were scheduled for three cycles of neoadjuvant systemic chemotherapy using bi-weekly FLOT-protocol followed by CRS + HIPEC. After this treatment 3 additional cycles of FLOT were given. During HIPEC Oxaliplatin was applied in a dosage of 200 mg/m2 and Docetaxel in a dosage of 80 mg/m2.ResultsAll patients underwent the standardized multimodal treatment including FLOT, CRS and HIPEC. This treatment resulted in an overall survival (OS) of 17 months in comparison to 6 months as the outcome of the classic treatments. Regression analysis demonstrated a Peritoneal Cancer Index (PCI) ≥ 12 as a negative factor for survival. Furthermore, we could see a worse prognosis by a higher temperature (>41,4 °C) of the chemotherapy used for the HIPEC. In consideration of the gender, the histomorphology and the Laurén-classification, we could develop a precise score to define the patient group which will benefit from this multimodal treatment with a prognosis improvement of 24 months.ConclusionNeoadjuvant chemotherapy using the FLOT-protocol followed by CRS + HIPEC seems to be associated with prolonged OS in patients with peritoneal carcinomatosis from gastric cancer. This treatment needs a critical evaluation for patients with a PCI ≥12. Furthermore, the accurate selection of patients suffering of PMGC by using the developed score can improve the OS of up to 24 months for a suitable group and it can avoid the extensive treatment for unsuitable patients.Copyright © 2019 Elsevier Ltd. All rights reserved.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:

- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.